Re-thinking the possible interaction between proton pump inhibitors and capecitabine

Proton Pump Inhibitors (PPI) rank within the top ten most prescribed medications in Europe and USA. A high frequency of PPI use has been reported amongst patients undergoing chemotherapy, to mitigate treatment-induced gastritis or gastro-oesophageal reflux. Several recent, mostly retrospective, obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Soo Hee, Molloy, Lara, Ang, Edmond, Helsby, Nuala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556389/
https://www.ncbi.nlm.nih.gov/pubmed/36098758
http://dx.doi.org/10.1007/s00280-022-04473-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556389/
https://www.ncbi.nlm.nih.gov/pubmed/36098758
http://dx.doi.org/10.1007/s00280-022-04473-9

Ejemplares similares